Skip to main content

Support WBUR

FDA Panel Endorses Gene Therapy For A Form Of Childhood Blindness

03:26
A panel of experts has recommended that the Food and Drug Administration approve a treatment developed by Spark Therapeutics for a rare form of blindness. (Spark Therapeutics)
A panel of experts has recommended that the Food and Drug Administration approve a treatment developed by Spark Therapeutics for a rare form of blindness. (Spark Therapeutics)

Support WBUR

Support WBUR

Listen Live